Alvotech and Advanz Pharma have received marketing authorisations from the European Commission (EC) for Gobivaz, the first biosimilar to...
Read MorePoolbeg Pharma has strengthened its intellectual property position in immunology and cancer immunotherapy with the news that the European...
Read MoreMursla Bio has announced a new collaboration with a leading global pharmaceutical company to accelerate biomarker-guided drug development in...
Read MoreEisai has presented new clinical data reinforcing the potential long-term benefits of lecanemab for people living with early Alzheimer’s...
Read MoreCNX Therapeutics has acquired the global Sativex® (nabiximols) business from Jazz Pharmaceuticals, reinforcing its position in the central nervous...
Read MoreSanthera Pharmaceuticals has reported positive topline results from a long-term analysis of AGAMREE (vamorolone) in boys with Duchenne muscular...
Read More